文献

J-GLOBAL ID：201902261035675351   整理番号：19A2840731

β-アドレナリン遮断薬カルベジロールは心筋梗塞後の心機能障害とリモデリングに対する脂肪由来幹細胞シートの改善作用を消失させる

β-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction

著者 (20件)： Adachi Maya (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Watanabe Mai (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Kurata Yasutaka (Department of Physiology II, Kanazawa Medical University Faculty of Medicine) ,  Inoue Yumiko (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Notsu Tomomi (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Yamamoto Kenshiro (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Horie Hiromu (Department of Cardiovascular Surgery, Tottori University Faculty of Medicine) ,  Tanno Shogo (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Morita Maki (Department of Plastic and Reconstructive Surgery, Tottori University Faculty of Medicine) ,  Miake Junichiro (Division of Cardiovascular Medicine, Department of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine) ,  Hamada Toshihiro (Department of Community-Based Family Medicine, Tottori University Faculty of Medicine) ,  Kuwabara Masanari (Department of Cardiology, Toranomon Hospital) ,  Nakasone Naoe (Department of Biological Regulation, Tottori University) ,  Ninomiya Haruaki (Department of Biological Regulation, Tottori University) ,  Tsuneto Motokazu (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Shirayoshi Yasuaki (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Yoshida Akio (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science) ,  Nishimura Motonobu (Department of Cardiovascular Surgery, Tottori University Faculty of Medicine) ,  Yamamoto Kazuhiro (Division of Cardiovascular Medicine, Department of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine) ,  Hisatome Ichiro (Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science)
資料名： Circulation Journal  (Circulation Journal)
巻： 83  号： 11  ページ： 2282-2291(J-STAGE)  発行年： 2019年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:心筋梗塞(MI)の治療は交感神経系(SNS)の阻害を含...

シソーラス用語： 病態モデル ,...
準シソーラス用語： 脂肪由来幹細胞 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2840731&from=J-GLOBAL&jstjournalNo=F0908A") }}

著者キーワード (5件)： 脂肪由来幹細胞 ,  アドレナリン受容体遮断薬 ,  カルベジロール ,  細胞シート ,  心筋梗塞

分類 (1件)： 循環系の基礎医学  (GJ01020K)

物質索引 (2件)： ノルエピネフリン ,  カルベジロール

引用文献 (39件)：

• 1. Pavillard LE, Marín-Aguilar F, Bullon P, Cordero MD. Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns. Pharmacol Res 2018; 131: 44-50.
• 2. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, et al. The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes: Part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006; 114: 2850-2870.
• 3. Singh K, Communal C, Sawyer DB, Colucci WS. Adrenergic regulation of myocardial apoptosis. Cardiovasc Res 2000; 45: 713-719.
• 4. Amin P, Singh M, Singh K. β-adrenergic receptor-stimulated cardiac myocyte apoptosis: Role of β1 integrins. J Signal Transduct 2011; 2011: Article ID 179057.
• 5. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: The same or separate death pathways? Exp Physiol 2004; 89: 407-416.

タイトルに関連する用語 (7件)： アドレナリン遮断薬 ,  カルベジロール ,  心筋梗塞 ,  心機能障害 ,  リモデリング ,  脂肪由来幹細胞 ,  改善作用